State Court Judge Sets Aside Verdict in Nation’s Second Actos Lawsuit Trial, 2,500 More Cases Pending in Federal Litigation
A Maryland jury found Takeda Pharmaceutical Co. liable for damages sought on behalf of a man whose Actos lawsuit alleged fatal bladder cancer injuries, but the verdict was promptly thrown out by the state court judge overseeing the case, after the jury also found that the Plaintiff’s personal habits may have partially contributed to his death, Bloomberg.com reports.
According to an article dated September 26th, state court jurors in Baltimore ordered the drug maker to pay over $1.7 million in damages to an ex-U.S. Army translator whose case alleged that the drug maker failed to properly warn he and his doctor about the bladder cancer risks associated with the diabetes drug. During the trial, Takeda presented evidence revealing that the Plaintiff consumed half a pack of cigarettes each day for 30 years ending in 1996, however, and pointed out that certain research tied bladder cancer to smoking. Immediately after the jury entered its ruling, the verdict was set aside by the judge.
Actos lawyers for the Plaintiff argued that he took the diabetes drug from 2007 to September 2011, during which time he was diagnosed with “high-grade bladder cancer.” He died just a few months later, his case states. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland)
Earlier this year, a trial for an Actos bladder cancer lawsuit concluded in April with a $6.5 million damage award to a Plaintiff whose suit blamed the diabetes drug for his illness. The judge in this case tossed out the verdict as well, which the family later appealed.
Some 2,500 Actos Lawsuit Claims Now Pending in Federal Litigation
In addition to the two cases that have already gone to trial in state court, thousands of Actos lawsuit filings have been consolidated in a federal litigation underway in the U.S. District Court, Western District of Louisiana. Recent court records indicate that some 2,500 Actos bladder cancer suits are now pending in the federal proceeding, which has scheduled its first bellwether trial to begin on January 27, 2014, with a second to follow on April 14, 2014. These cases similarly allege that Takeda failed to adequately warn doctors and patients about the potential for its diabetes medication to cause cancer. (In re: Actos Product Liability Litigation, MDL No. 2299)
File an Actos Lawsuit Today
For more information about filing an Actos bladder cancer lawsuit, contact an attorney at Bernstein Liebhard LLP today. You may be eligible to join the thousands of individuals who have taken the first steps toward realizing the justice they deserve. Call us today at (877) 779-1414.